Decreases from baseline in C3M and C4M through Week 100 did not reach statistical significance.
← all excerpts
Correlation of changes in inflammatory and collagen biomarkers with durable guselkumab efficacy through 2 years in participants with active psoriatic arthritis: results from a phase III randomized controlled trial.
1
—
—